The global animal vaccines market achieved a valuation of $12 billion in 2021, and it is set to reach $29 billion by 2032. This substantial growth is underpinned by an anticipated compound annual growth rate (CAGR) of 9.2% from 2022 to 2032. The rising prevalence of diseases among cattle and canine populations is fueling the demand for animal vaccines. Additionally, significant investments in...